Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 424B3 Offering Prospectus
  2. 4 Insider Changes in Ownership
  3. 10-Q Report Quarterly Report
  4. DEFA14A Proxy Proxy Materials
  5. DEF 14A Proxy Proxy Statement
  6. POS AM Other Post-effective Amendment for Registration Statement
  7. EFFECT Other Notice of Effectiveness
  8. 424B3 Offering Prospectus
  9. POS AM Other Post-effective Amendment for Registration Statement
  10. 10-K Report Annual Report
  11. 424B3 Offering Prospectus
  12. 424B3 Offering Prospectus
  13. EFFECT Other Notice of Effectiveness
  14. S-1/A Offering Registration Statement
  15. 4 Insider Changes in Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Executive or director change
  18. S-1/A Offering Registration Statement
  19. S-1 Offering Registration Statement
  20. 8-K Event Executive or director change

Page 33 of 72 · 1,429 filings